Title of article
The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine
Author/Authors
P. Tfelt-Hansen، نويسنده , , P. Henry، نويسنده , , L. J. Mulder، نويسنده , , R. G. Scheldewaert، نويسنده , , J. Schoenen، نويسنده , , G. Chazot، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1995
Pages
4
From page
923
To page
926
Abstract
Aspirin is commonly used to treat migraine attacks, although sumatriptan, a much more expensive treatment, is also effective.
We compared a combination of lysine acetylsalicylate (equivalent to 900 mg aspirin) and 10 mg metoclopramide (LAS+MTC) with oral sumatriptan (100 mg) and placebo in 421 patients with migraine. LAS+MTC was as effective as sumatriptan with a decrease of headache from severe or moderate to mild or none of 57% and 53%, respectively, for the first migraine attack treated. Both treatments were better than placebo (success rate 24%, p<0·0001). LAS+MTC was significantly more effective in the treatment of nausea than sumatriptan (p<0·0001) and was better tolerated (adverse events in 18% and 28%, respectively, p<0·05).
LAS+MTC is as effective as sumatriptan in the treatment of migraine attacks. It is also much cheaper.
Journal title
The Lancet
Serial Year
1995
Journal title
The Lancet
Record number
563110
Link To Document